Tirzepatide is a synthetic peptide consisting of 39 amino acids with a half-life that allows for weekly administration. It is currently under investigation for its potential therapeutic applications in managing type 2 diabetes and aiding weight loss in adults with obesity or overweight with at least one weight-related condition.